Is ALZN or ANIX more undervalued in 2026?

CirclFi compares Alzamend Neuro, Inc. (ALZN) and Anixa Biosciences, Inc. (ANIX) using 13 institutional-grade valuation models. ALZN has a Quality of Company score of 4.1/10 while ANIX scores 4.4/10.

Which is a better buy — ALZN or ANIX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ALZN and ANIX valuations compare?

ALZN at $1.15 and ANIX at $2.70 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ALZN vs ANIX Valuation Comparison 2026 — Intrinsic Value Analysis

ALZN

Biotechnology

Alzamend Neuro, Inc.

Quality

4.1

out of 10

Value Trap

SAFE

Price

$1.15

Last close

Models

7/13

Active

ANIX

Biotechnology

Anixa Biosciences, Inc.

Quality

4.4

out of 10

Value Trap

SAFE

Price

$2.70

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ALZN Fair Value	ALZN Upside	ANIX Fair Value	ANIX Upside
Bayesian DCF	Intrinsic	$0.70	-39.3%	$0.76	-71.7%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.05	-95.4%	$0.04	-98.7%
Dynamic NAV	Asset-Based	$2.27	+97.0%	$0.79	-70.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ALZN vs ANIX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ALZN vs ANIX — Which Stock Is More Undervalued?

ANIX scores higher with a 4.4/10 quality rating vs ALZN's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Alzamend Neuro, Inc. (ALZN) and Anixa Biosciences, Inc. (ANIX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ALZN currently trades at $1.15 with a QOC of 4.1/10, while ANIX trades at $2.70 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).